The new data builds upon previously reported 6- and 12-month positive results from adult patients treated in the same study.

Tenpoint Therapeutics submitted a new drug application to the FDA for Brimochol PF, an eye drop for presbyopia treatment, ...

First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month. A ...

Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep ... eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide.

AbbVie’s Rinvoq (upadacitinib) has been granted marketing authorisation by the European Commission (EC) to treat giant cell ...

Discover the warning signs and treatment options for myopic macular degeneration, a serious eye condition affecting people ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when ...

This is where the therapy comes in. In your first sessions with a therapist, you tend to unload the problems that are ...

Caregivers often cite three top challenges: financial strain, emotional stress and loss of freedom. Here are practical tips ...

There has been debate about the value of promoting diversity, equity, and inclusion. Viewing this debate through the lens of history is important for persons with disabilities.

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...